240 related articles for article (PubMed ID: 18320064)
1. Open-label comparative clinical study of chlorproguanil-dapsone fixed dose combination (Lapdap) alone or with three different doses of artesunate for uncomplicated Plasmodium falciparum malaria.
Wootton DG; Opara H; Biagini GA; Kanjala MK; Duparc S; Kirby PL; Woessner M; Neate C; Nyirenda M; Blencowe H; Dube-Mbeye Q; Kanyok T; Ward S; Molyneux M; Dunyo S; Winstanley PA
PLoS One; 2008 Mar; 3(3):e1779. PubMed ID: 18320064
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of chlorproguanil, dapsone, artesunate and their major metabolites in patients during treatment of acute uncomplicated Plasmodium falciparum malaria.
Miller AK; Bandyopadhyay N; Wootton DG; Duparc S; Kirby PL; Winstanley PA; Ward SA
Eur J Clin Pharmacol; 2009 Oct; 65(10):977-87. PubMed ID: 19517101
[TBL] [Abstract][Full Text] [Related]
3. Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria.
Premji Z; Umeh RE; Owusu-Agyei S; Esamai F; Ezedinachi EU; Oguche S; Borrmann S; Sowunmi A; Duparc S; Kirby PL; Pamba A; Kellam L; Guiguemdé R; Greenwood B; Ward SA; Winstanley PA
PLoS One; 2009 Aug; 4(8):e6682. PubMed ID: 19690618
[TBL] [Abstract][Full Text] [Related]
4. Chlorproguanil-dapsone-artesunate versus chlorproguanil-dapsone: a randomized, double-blind, phase III trial in African children, adolescents, and adults with uncomplicated Plasmodium falciparum malaria.
Tiono AB; Dicko A; Ndububa DA; Agbenyega T; Pitmang S; Awobusuyi J; Pamba A; Duparc S; Goh LE; Harrell E; Carter N; Ward SA; Greenwood B; Winstanley PA
Am J Trop Med Hyg; 2009 Dec; 81(6):969-78. PubMed ID: 19996424
[TBL] [Abstract][Full Text] [Related]
5. Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.
Ndiaye JL; Randrianarivelojosia M; Sagara I; Brasseur P; Ndiaye I; Faye B; Randrianasolo L; Ratsimbasoa A; Forlemu D; Moor VA; Traore A; Dicko Y; Dara N; Lameyre V; Diallo M; Djimde A; Same-Ekobo A; Gaye O
Malar J; 2009 Jun; 8():125. PubMed ID: 19505304
[TBL] [Abstract][Full Text] [Related]
6. Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria.
Winstanley P
Trop Med Int Health; 2001 Nov; 6(11):952-4. PubMed ID: 11703851
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial.
von Seidlein L; Milligan P; Pinder M; Bojang K; Anyalebechi C; Gosling R; Coleman R; Ude JI; Sadiq A; Duraisingh M; Warhurst D; Alloueche A; Targett G; McAdam K; Greenwood B; Walraven G; Olliaro P; Doherty T
Lancet; 2000 Jan; 355(9201):352-7. PubMed ID: 10665554
[TBL] [Abstract][Full Text] [Related]
8. An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.
Owusu-Agyei S; Asante KP; Owusu R; Adjuik M; Amenga-Etego S; Dosoo DK; Gyapong J; Greenwood B; Chandramohan D
PLoS One; 2008 Jun; 3(6):e2530. PubMed ID: 18575626
[TBL] [Abstract][Full Text] [Related]
9. Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response.
Krudsood S; Imwong M; Wilairatana P; Pukrittayakamee S; Nonprasert A; Snounou G; White NJ; Looareesuwan S
Trans R Soc Trop Med Hyg; 2005 Feb; 99(2):142-9. PubMed ID: 15607340
[TBL] [Abstract][Full Text] [Related]
10. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
Blanshard A; Hine P
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
[TBL] [Abstract][Full Text] [Related]
11. Therapy of uncomplicated falciparum malaria: a randomized trial comparing artesunate plus sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine alone in Irian Jaya, Indonesia.
Tjitra E; Suprianto S; Currie BJ; Morris PS; Saunders JR; Anstey NM
Am J Trop Med Hyg; 2001 Oct; 65(4):309-17. PubMed ID: 11693875
[TBL] [Abstract][Full Text] [Related]
12. The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate.
Peters W; Stewart LB; Robinson BL
Ann Trop Med Parasitol; 2005 Jul; 99(5):457-72. PubMed ID: 16004705
[TBL] [Abstract][Full Text] [Related]
13. Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.
Sulo J; Chimpeni P; Hatcher J; Kublin JG; Plowe CV; Molyneux ME; Marsh K; Taylor TE; Watkins WM; Winstanley PA
Lancet; 2002 Oct; 360(9340):1136-43. PubMed ID: 12387962
[TBL] [Abstract][Full Text] [Related]
14. Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.
Krudsood S; Looareesuwan S; Silachamroon U; Chalermrut K; Pittrow D; Cambon N; Mueller EA
Am J Trop Med Hyg; 2002 Nov; 67(5):465-72. PubMed ID: 12479545
[TBL] [Abstract][Full Text] [Related]
15. Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.
Held J; Supan C; Salazar CL; Tinto H; Bonkian LN; Nahum A; Moulero B; Sié A; Coulibaly B; Sirima SB; Siribie M; Otsyula N; Otieno L; Abdallah AM; Kimutai R; Bouyou-Akotet M; Kombila M; Koiwai K; Cantalloube C; Din-Bell C; Djeriou E; Waitumbi J; Mordmüller B; Ter-Minassian D; Lell B; Kremsner PG
Lancet Infect Dis; 2015 Dec; 15(12):1409-19. PubMed ID: 26342427
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of safety and effectiveness of chlorproguanil-dapsone and lumefantrine-artemether for uncomplicated malaria in children in the Gambia.
Dunyo S; Sirugo G; Sesay S; Bisseye C; Njie F; Adiamoh M; Nwakanma D; Diatta M; Janha R; Sisay Joof F; Temple B; Snell P; Conway D; Walton R; Cheung YB; Milligan P
PLoS One; 2011; 6(6):e17371. PubMed ID: 21666744
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.
Noedl H; Krudsood S; Chalermratana K; Silachamroon U; Leowattana W; Tangpukdee N; Looareesuwan S; Miller RS; Fukuda M; Jongsakul K; Sriwichai S; Rowan J; Bhattacharyya H; Ohrt C; Knirsch C
Clin Infect Dis; 2006 Nov; 43(10):1264-71. PubMed ID: 17051490
[TBL] [Abstract][Full Text] [Related]
18. Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi.
Bell DJ; Wootton D; Mukaka M; Montgomery J; Kayange N; Chimpeni P; Hughes DA; Molyneux ME; Ward SA; Winstanley PA; Lalloo DG
Malar J; 2009 Aug; 8():204. PubMed ID: 19709418
[TBL] [Abstract][Full Text] [Related]
19. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
20. Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial.
Obonyo CO; Ochieng F; Taylor WR; Ochola SA; Mugitu K; Olliaro P; ter Kuile F; Oloo AJ
Trans R Soc Trop Med Hyg; 2003; 97(5):585-91. PubMed ID: 15307433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
